Roka Bioscience Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Roka Bioscience (ROKA) Reports Q1 Loss of $1.53
May 11, 2017 4:04 PM EDTRoka Bioscience (NASDAQ: ROKA) reported Q1 EPS of ($1.53), versus ($4.66) reported last year. Revenue for the quarter came in at $2 million, versus $1.6 million reported last year.
As of March 31, 2017, the Company had cash and cash equivalents and marketable securities of $16.2 million compared with $24.8 million at December... More
